Strata Skin Sciences Income from Continuous Operations 2010-2024 | SSKN
Strata Skin Sciences income from continuous operations from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| Strata Skin Sciences Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2023 | $-11 |
| 2022 | $-6 |
| 2021 | $-3 |
| 2020 | $-4 |
| 2019 | $-4 |
| 2018 | $-4 |
| 2017 | $-22 |
| 2016 | $-3 |
| 2015 | $-25 |
| 2014 | $-14 |
| 2013 | $-26 |
| 2012 | $-23 |
| 2011 | $-20 |
| 2010 | $-20 |
| 2009 | $-18 |
| Strata Skin Sciences Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-0 |
| 2024-03-31 | $-3 |
| 2023-12-31 | $-4 |
| 2023-09-30 | $-1 |
| 2023-06-30 | $-3 |
| 2023-03-31 | $-3 |
| 2022-12-31 | $-0 |
| 2022-09-30 | $-1 |
| 2022-06-30 | $-2 |
| 2022-03-31 | $-3 |
| 2021-12-31 | $-1 |
| 2021-09-30 | $-1 |
| 2021-06-30 | $1 |
| 2021-03-31 | $-2 |
| 2020-12-31 | $-0 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $-2 |
| 2020-03-31 | $-1 |
| 2019-12-31 | $-1 |
| 2019-09-30 | $-1 |
| 2019-06-30 | $-1 |
| 2019-03-31 | $-1 |
| 2018-12-31 | $0 |
| 2018-09-30 | $-1 |
| 2018-06-30 | $-2 |
| 2018-03-31 | $-2 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-14 |
| 2017-06-30 | $-1 |
| 2017-03-31 | $-2 |
| 2016-12-31 | $-1 |
| 2016-09-30 | $-2 |
| 2016-06-30 | $0 |
| 2016-03-31 | $-1 |
| 2015-12-31 | $-1 |
| 2015-09-30 | $-9 |
| 2015-06-30 | $-8 |
| 2015-03-31 | $-7 |
| 2014-12-31 | $-5 |
| 2014-09-30 | $-2 |
| 2014-06-30 | $1 |
| 2014-03-31 | $-8 |
| 2013-12-31 | $-5 |
| 2013-09-30 | $-7 |
| 2013-06-30 | $-7 |
| 2013-03-31 | $-7 |
| 2012-12-31 | $-6 |
| 2012-09-30 | $-5 |
| 2012-06-30 | $-5 |
| 2012-03-31 | $-6 |
| 2011-12-31 | $-5 |
| 2011-09-30 | $-6 |
| 2011-06-30 | $-5 |
| 2011-03-31 | $-5 |
| 2010-12-31 | $-5 |
| 2010-09-30 | $-5 |
| 2010-06-30 | $-5 |
| 2010-03-31 | $-5 |
| 2009-12-31 | $-6 |
| 2009-09-30 | $-5 |
| 2009-06-30 | $-4 |
| 2009-03-31 | $-4 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.012B | $0.033B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $40.428B | 21.75 |
| Tempus AI (TEM) | United States | $7.918B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.215B | 1157.72 |
| Axonics (AXNX) | United States | $3.513B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.503B | 203.88 |
| 10x Genomics (TXG) | United States | $2.660B | 0.00 |
| Enovis (ENOV) | United States | $2.437B | 17.67 |
| Azenta (AZTA) | United States | $2.413B | 137.03 |
| Privia Health (PRVA) | United States | $2.280B | 158.92 |
| IRhythm Technologies (IRTC) | United States | $2.219B | 0.00 |
| Omnicell (OMCL) | United States | $1.968B | 64.82 |
| Clover Health Investments (CLOV) | United States | $1.492B | 0.00 |
| Schrodinger (SDGR) | United States | $1.436B | 0.00 |
| Phreesia (PHR) | United States | $1.389B | 0.00 |
| Standard BioTools (LAB) | United States | $0.753B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.694B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.538B | 456.00 |
| Health Catalyst (HCAT) | United States | $0.529B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.406B | 0.00 |
| Talkspace (TALK) | United States | $0.343B | 0.00 |
| Pulmonx (LUNG) | United States | $0.329B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.286B | 0.00 |
| TruBridge (TBRG) | United States | $0.183B | 13.44 |
| P3 Health Partners (PIII) | United States | $0.165B | 0.00 |
| American Well (AMWL) | United States | $0.147B | 0.00 |
| Augmedix (AUGX) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.090B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.055B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| 111 (YI) | China | $0.051B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| CareCloud (CCLD) | United States | $0.045B | 0.00 |
| Movano (MOVE) | United States | $0.036B | 0.00 |
| Outset Medical (OM) | United States | $0.034B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.025B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.024B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.018B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Syra Health (SYRA) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |